Can a small biotech challenge Alexion's Soliris? With Empaveli's FDA nod, Apellis can give it a try

Retrieved on: 2021-05-14 22:33:01

Tags for this article:

Click the tags to see associated articles and topics

Can a small biotech challenge Alexion's Soliris? With Empaveli's FDA nod, Apellis can give it a try. View article details on hiswai:

Excerpt

The destruction is driven by an uncontrolled immune system and defective ... C5 inhibitors, is designed to regulate that excessive immune response.

Article found on: www.fiercepharma.com